Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
Provider: ValuEngine, Inc.
Provider: Reuters Investment Profile
Provider: Ford Investor Services, Inc.

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Esperion Therapeutics Inc Announces Pricing of Initial Public Offering

Wednesday, 26 Jun 2013 08:00am EDT 

Esperion Therapeutics Inc announced the pricing of its initial public offering of 5,000,000 shares of its common stock at a price to the public of $14.00 per share. The shares are expected to begin trading on the NASDAQ Global Market on June 26, 2013 under the symbol 'ESPR.' In addition, Esperion has granted the underwriters a 30-day option to purchase up to an additional 750,000 shares of common stock to cover over-allotments, if any. Credit Suisse Securities (USA) LLC and Citigroup Global Markets Inc. are acting as joint book-running managers for the offering. JMP Securities LLC and Stifel, Nicolaus & Company, Incorporated are acting as co-managers.